ArticleBiopreservation and biobanking2019
The Utilization of Biospecimens: Impact of the Choice of Biobanking Model.
Article in Biopreservation and biobanking, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Patient-specific trophoblast stem cells for placental medicine.Trends in molecular medicine · 2026Review
- Future-Proofing Biobanks Is Essential for Long-Term Sustainability: Workshop Report.Biopreservation and biobanking · 2026Article
- Article
- Utilization Patterns of Hospital Biobank Samples: Time to First Use and Material-Specific Demand.Journal of clinical medicine · 2026Article
- Decentralized Biobanking Pathway to Precision Medicine: Futures Study.Journal of medical Internet research · 2025Article
- Applying Findable, Accessible, Interoperable, and Reusable Principles to Biospecimens and Biobanks.Biopreservation and biobanking · 2024Article
- The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years.Molecular cancer therapeutics · 2023Article
- Consensus Definition of Blood Samples from the Subcategorized Normal Controls in the Korea Biobank Network.Journal of clinical medicine · 2023Article
- The Use of Human Tissues for Research: What Investigators Need to Know.Alternatives to laboratory animals : ATLA · 2022Article
- The Availability of Human Biospecimens to Support Biomarker Research.Biomarker insights · 2022Review
- Building Research Support Capacity across Human Health Biobanks during the COVID-19 Pandemic.Biomarker insights · 2021Article
- Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability.Biomarker insights · 2021Article
- Biobanking for Cancer Biomarker Research: Issues and Solutions.Biomarker insights · 2020Review
- The Scale, Collections, and Biospecimen Distribution of Grade A Tertiary Hospital Biobanks in China: A National Survey.Frontiers in medicine · 2020Article
- The Importance of Human Tissue Bioresources in Advancing Biomedical Research.Biopreservation and biobanking · 2019Article
- Ensuring Effective Utilization of Biospecimens: Design, Marketing, and Other Important Approaches.Biopreservation and biobanking · 2019Article
- Commentary on Improving Biospecimen Utilization by Classic Biobanks: Identifying Past and Minimizing Future Mistakes.Biopreservation and biobanking · 2019Article
- Lessons Learned During Three Decades of Operations of Two Prospective Bioresources.Biopreservation and biobanking · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The term research "biobank" is one of multiple names (e.g., bioresource, biorepository,) used to designate an entity that receives, collects, processes, stores, and/or distributes biospecimens or other biospecimen-related products (e.g., data) to support research. There are multiple organizational models of biobanking used by bioresources, but the primary goal of all bioresources should not be simply to collect biospecimens, but ultimately to distribute almost all collected biospecimens and/or data to support scientific research; bioresources should serve as "biodistributors" rather than "biovaults." The appropriate choice of model is the first step in ensuring optimal biospecimen utilization by a bioresource. This article discusses some of the different models that may be used alone or in combination by a bioresource providing biospecimens for research; it describes the factors affecting the choice of the most appropriate model or models, the advantages and disadvantages of the various models, and a discussion of the impact of the choice of the model on biospecimen utilization. Frequently, problems with biospecimen utilization are not caused by any single model, but rather a mismatch between the choice of model and goals of the bioresource, and/or problems with the subsequent design, goals, operations, and management of the bioresource after a model is selected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.